Loading clinical trials...
Loading clinical trials...
Post-authorisation Safety Study of NOCDURNA for the Symptomatic Treatment of Nocturia Due to Idiopathic Nocturnal Polyuria: A Multi-country Cohort Study Using Secondary Data
A study using medical records to evaluate safety issues for the NOCDURNA drug using national register data from Denmark and Sweden, and a health care register covering parts of Germany.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Danish Health Care Registry
Copenhagen, Denmark
German Health Care Register
Bremen, Germany
Socialstryrelsen
Stockholm, Sweden
Start Date
July 13, 2021
Primary Completion Date
November 1, 2023
Completion Date
November 1, 2023
Last Updated
December 3, 2025
1,099,551
ACTUAL participants
NOCDURNA Cohort
OTHER
LUTS Cohort
OTHER
Lead Sponsor
Ferring Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions